SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-028624
Filing Date
2019-05-10
Accepted
2019-05-10 16:12:09
Documents
40
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a19-7704_110q.htm 10-Q 878612
2 EX-31.1 a19-7704_1ex31d1.htm EX-31.1 10395
3 EX-31.2 a19-7704_1ex31d2.htm EX-31.2 10904
4 EX-32.1 a19-7704_1ex32d1.htm EX-32.1 6426
5 EX-32.2 a19-7704_1ex32d2.htm EX-32.2 6948
  Complete submission text file 0001104659-19-028624.txt   2336798

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gtxi-20190331.xml EX-101.INS 235672
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gtxi-20190331.xsd EX-101.SCH 26081
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gtxi-20190331_cal.xml EX-101.CAL 19191
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gtxi-20190331_def.xml EX-101.DEF 67197
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT gtxi-20190331_lab.xml EX-101.LAB 224929
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gtxi-20190331_pre.xml EX-101.PRE 148052
Mailing Address 17 W PONTOTOC AVE. SUITE 100 MEMPHIS TN 38103
Business Address 17 W PONTOTOC AVE. SUITE 100 MEMPHIS TN 38103 901-523-9700
GTX INC /DE/ (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50549 | Film No.: 19815037
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1